BeOne Medicines ONC
NASDAQ ONC
$359.97 -5.03 (-1.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Current Deferred Revenue (2015 - 2023)

BeOne Medicines' (ONC) quarterly Current Deferred Revenue came in at $159.0 million in Q2 2023, down 2.67% year-over-year from $163.4 million in Q2 2022, and down 14.26% quarter-over-quarter from $185.5 million in Q1 2023.

Analysis

BeOne Medicines (ONC) Current Deferred Revenue (2015 - 2023) Analysis & Trends

BeOne Medicines (ONC) has reported Current Deferred Revenue for 8 consecutive years, with $159.0 million the latest figure, recorded in Q2 2023.

  • On a quarterly basis, Current Deferred Revenue fell 2.67% year-over-year to $159.0 million in Q2 2023; TTM through Jun 2023 was $159.0 million, a 2.67% decrease from a year earlier, with the FY2022 full-year figure at $213.9 million, up 14.11% from the prior year.
  • Current Deferred Revenue was $159.0 million for Q2 2023 at BeOne Medicines, down from $185.5 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $213.9 million in Q4 2022 and troughed at $17.5 million in Q1 2019.
  • A 4-year average of $131.2 million and a median of $159.0 million in 2023 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue soared 156.89% in 2022 and dropped 2.67% in 2023, its largest moves.
  • Over 4 years, Current Deferred Revenue stood at $17.5 million in 2019, then soared by 970.69% to $187.4 million in 2021, then gained by 14.11% to $213.9 million in 2022, then fell by 25.64% to $159.0 million in 2023.
  • The last three Current Deferred Revenue figures came in at $159.0 million (Q2 2023), $185.5 million (Q1 2023), and $213.9 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 BeOne Medicines 41.25 Bn 36.15 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 159.03 Mn
Mar 31, 2023 185.48 Mn
Dec 31, 2022 213.86 Mn
Sep 30, 2022 144.98 Mn
Jun 30, 2022 163.40 Mn
Mar 31, 2022 163.66 Mn
Dec 31, 2021 187.41 Mn
Sep 30, 2021 72.63 Mn
Jun 30, 2021 63.61 Mn
Mar 31, 2021 71.65 Mn
Mar 31, 2019 17.50 Mn
Dec 31, 2018 18.14 Mn
Sep 30, 2018 16.71 Mn
Jun 30, 2018 15.30 Mn
Mar 31, 2018 14.01 Mn
Dec 31, 2017 12.23 Mn
Sep 30, 2017 9.13 Mn
Mar 31, 2016 393,000.00
Dec 31, 2015 1.07 Mn
API Access

BeOne Medicines Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ONC&period=max&api_key=YOUR_API_KEY